Tarsus to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Tarsus Pharmaceuticals (NASDAQ: TARS) has announced its participation in three major upcoming investor conferences in June 2025. The company will present at the William Blair 45th Annual Growth Stock Conference on June 3rd at 6:00 AM PT, the Jefferies Global Healthcare Conference on June 4th at 12:45 PM PT, and the Goldman Sachs 46th Annual Global Healthcare Conference on June 9th at 10:20 AM PT. Live webcasts will be available on Tarsus's website, with replays accessible within 48 hours and archived for a limited time.

IRVINE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences:

• William Blair 45^th Annual Growth Stock Conference on Tuesday, June 3^rd, at 6:00 a.m. PT / 8:00 a.m. CT
• Jefferies Global Healthcare Conference on Wednesday, June 4^th, at 12:45 p.m. PT / 3:45 p.m. ET
• Goldman Sachs 46^th Annual Global Healthcare Conference on Monday, June 9^th, at 10:20 a.m. PT / 1:20 p.m. ET
  

Live webcasts and additional information can be accessed on the events section of the Tarsus website. Replays will be available on the Tarsus website within 48 hours and will be archived for a limited time.

About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY^® (lotilaner ophthalmic solution) 0.25% is FDA approved in the United States for the treatment of Demodex
blepharitis. Tarsus is also developing TP-04 for the potential treatment of Ocular Rosacea, and TP-05 as an oral tablet for the potential prevention of Lyme disease.

Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com

Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com

FAQ

Which investor conferences will Tarsus Pharmaceuticals (TARS) attend in June 2025?

Tarsus will attend three conferences: William Blair Growth Stock Conference (June 3), Jefferies Global Healthcare Conference (June 4), and Goldman Sachs Global Healthcare Conference (June 9).

What time is Tarsus Pharmaceuticals' (TARS) presentation at the William Blair conference?

Tarsus will present at the William Blair conference on June 3rd, 2025, at 6:00 AM PT / 8:00 AM CT.

Where can investors watch Tarsus Pharmaceuticals' (TARS) conference presentations?

Live webcasts can be accessed through the events section of the Tarsus website. Replays will be available within 48 hours and archived for a limited time.

When is Tarsus Pharmaceuticals (TARS) presenting at the Goldman Sachs Healthcare Conference?

Tarsus will present at the Goldman Sachs Global Healthcare Conference on June 9th, 2025, at 10:20 AM PT / 1:20 PM ET.